Transcatheter aortic valve implantation in patient with combined aortic and subaortic membrane stenosis: a case report
2024

Transcatheter Aortic Valve Implantation for Aortic Stenosis and Subaortic Membrane

publication Evidence: low

Author Information

Author(s): Tayel Hesham, Elhakim Abdelrahman, Elsoudi Mohamed, Nour Amira, Saad Mohammed

Primary Institution: Menofia University

Hypothesis

Can transcatheter aortic valve implantation (TAVI) effectively treat symptomatic aortic stenosis combined with subaortic membrane stenosis in high-risk patients?

Conclusion

TAVI is a feasible and effective treatment for patients with symptomatic aortic stenosis and subaortic membrane stenosis, especially those at high surgical risk.

Supporting Evidence

  • The combination of symptomatic aortic stenosis and subaortic membrane is rare and challenging to manage.
  • Transcatheter aortic valve implantation can be performed safely in high-risk patients.
  • Three-month follow-up showed no complications after the procedure.

Takeaway

Doctors can use a special heart valve procedure to help older patients with a rare heart problem that makes it hard for blood to flow.

Methodology

The patient underwent transoesophageal echocardiography and transcatheter aortic valve implantation after careful evaluation by a heart team.

Potential Biases

Potential bias due to the authors' affiliations with the institutions involved in the study.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

A 78-year-old male with a history of chronic renal failure.

Digital Object Identifier (DOI)

10.1093/ehjcr/ytae621

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication